![]() |
|
RESÚMENES ABRIL 2009 |
Schizophrenia-Psychotic Disorders & Antipsychotics
(Haga un click en la información del journal
para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la región iberoamericana
(algunos artículos requieren ir a la tabla de contenidos del
número actual de la revista)
3! - Mortality
and tardive dyskinesia: long-term study using the
Charles
E. Dean, Paul D. Thuras
The British Journal of Psychiatry (2009) 194:
360-364
Gratis 4 - Maintenance of Response with
Atypical Antipsychotics in the Treatment of Schizophrenia: a Post-hoc Analysis
of 5 Double-blind, Randomized, Clinical Trials
Virginia Stauffer, Haya
Ascher-Svanum, Lin Liu, Tamara
Ball and Robert Conley
3< - Aripiprazole Prescribing Patterns and Side Effects in
Elderly Psychiatric Inpatients
Coley, Kim C; Scipio, Tina M; Ruby, Christine; Lenze, Eric J; Fabian,
Tanya J
Journal of Psychiatric Practice: March 2009 - Volume
15 - Issue 2 - pp 150-153
GRATIS 3!
- Time-Lapse Mapping
of Cortical Changes in Schizophrenia with Different Treatments
Paul M. Thompson, George
Bartzokis, Kiralee M. Hayashi, Andrea D. Klunder, Po H. Lu, Nancy Edwards,
Michael S. Hong, Michael Yu, Jennifer A. Geaga, Arthur W. Toga, Cecil Charles,
Diana O. Perkins, Joseph McEvoy, Robert M. Hamer, Mauricio Tohen, Gary D.
Tollefson, Jeffrey A. Lieberman and the HGDH Study Group
Cerebral Cortex 2009
19(5):1107-1123
3 - Early striatal hypertrophy in first-episode psychosis
within 3 weeks of initiating antipsychotic drug treatment
S. E. Chua, Y. Deng,
E. Y. H. Chen, C. W. Law, C. P. Y. Chiu, C. Cheung, J. C. H. Wong, N.
Lienenkaëmper, V. Cheung, J. Suckling and G. M. McAlonan
Psychological
Medicine (2009), 39 : 793-800
3! - Body
composition in psychotic disorders: a general population survey
S. E.
Saarni, S. I. Saarni, M. Fogelholm, M. Heliövaara, J. Perälä, J. Suvisaari and J.
Lönnqvist
Psychological
Medicine (2009), 39:801-810
3 - The use of ziprasidone in clinical practice: Analysis
of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring
survey
Friederike Vogel, Reinhard Gansmüller, Thomas
Leiblein, Otto Dietmaier, Hans Wassmuth, Gerhard Gründer and Christoph Hiemke
European
Psychiatry. Volume 24, Issue 3, April 2009, Pages 143-148
5< - A pilot study of the safety and efficacy of
amisulpride and risperidone in elderly psychotic patients
M. Riedel, F.X. Eich and H.J. Möller
European Psychiatry. Volume 24, Issue 3, April 2009, Pages 149-153
3! - Belgian
Schizophrenia Outcome Survey – Results of a 2-year naturalistic study in
patients stabilised on monotherapy with olanzapine, risperidone or haloperidol
J. Peuskens, B. Gillain, D. De Graeve, B. Van Vleymen and A. Albert
European Psychiatry. Volume
24, Issue 3, April 2009, Pages 154-163
3 - How can antipsychotics cause diabetes mellitus?
Insights based on receptor-binding profiles, humoral factors and transporter
proteins
F.C.J. Starrenburg and J.P.A.M. Bogers
European Psychiatry. Volume 24, Issue 3, April 2009, Pages 164-170
3 - Olanzapine shifts the temporal relationship between
the daily acrophase of serum prolactin and cortisol concentrations rhythm in
healthy men
Solrun Vidarsdottir, Ferdinand Roelfsema, Marijke Frolich and Hanno Pijl
Psychoneuroendocrinology. Volume 34, Issue 5, June 2009, Pages 705-712
3! - Amisulpride for
the treatment of very-late-onset schizophrenia-like psychosis
Constantin Psarros,
Christos G. Theleritis, Thomas J. Paparrigopoulos, Antonios M. Politis, George
N. Papadimitriou
International
Journal of Geriatric Psychiatry. Volume 24 Issue
5, Pages 518 - 522
3! -
McLean-Harvard International First-Episode Project: Two-Year Stability of
DSM-IV Diagnoses in 500 First-Episode Psychotic Disorder Patients
Paola Salvatore, Ross J. Baldessarini,
Mauricio Tohen, Hari-Mandir K. Khalsa, Jesus Perez Sanchez-Toledo, Carlos A.
Zarate, Jr., Eduard Vieta, and Carlo Maggini
J
Clin Psychiatry 2009;70(4):458-466
3 -
Effectiveness and Tolerability of Oral Ziprasidone in Psychiatric Inpatients
With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: A
Multicenter, Prospective, and Naturalistic Study
Marina Díaz-Marsá, Sara Sánchez, and
Fernando Rico-Villademoros, for the ZIP-IIG-79 Study Group
J
Clin Psychiatry 2009;70(4):509-517
3! - A
24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in
Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With
Olanzapine, Quetiapine, or Risperidone
John W. Newcomer, Robert E. Ratner, Jan W.
Eriksson, Robin Emsley, Didier Meulien, Frank Miller, Julia Leonova-Edlund,
Ronald W. Leong, and Martin Brecher
J
Clin Psychiatry 2009;70(4):487-499
5< - A
Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32
People With Schizophrenia
Deanna L. Kelly, Robert W. Buchanan, Douglas
L. Boggs, Robert P. McMahon, Dwight Dickinson, Matthew Nelson, James M. Gold,
M. Patricia Ball, Stephanie Feldman, Fang Liu, and Robert R. Conley
J
Clin Psychiatry 2009;70(4):518-525
3 -
Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged
and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A
Randomized Controlled Trial
Sidney Zisook, John W. Kasckow, Shahrokh
Golshan, Ian Fellows, Ellen Solorzano, David Lehman, Somaia Mohamed, and Dilip
V. Jeste
J
Clin Psychiatry 2009;70(4):562-571
5 -
A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus
Aripiprazole in the Treatment of Schizophrenia
John M. Kane, Olawale Osuntokun, Ludmila A.
Kryzhanovskaya, Wen Xu, Virginia L. Stauffer, Susan B. Watson, and Alan Breier
J
Clin Psychiatry 2009;70(4):572-581
3 -
Akathisia and second-generation antipsychotic drugs
Kumar, Rajeev;
Sachdev, Perminder S
Current
Opinion in Psychiatry: May 2009 - Volume 22 - Issue 3 - p 293-299
4 -
Metabolic Changes Associated With Second-Generation Antipsychotic Use in
Alzheimer's Disease Patients: The CATIE-AD Study
Ling
Zheng, Wendy J. Mack, Karen S. Dagerman, John K. Hsiao, Barry D. Lebowitz,
Constantine G. Lyketsos, T. Scott Stroup, David L. Sultzer, Pierre N. Tariot,
Cheryl Vigen, and Lon S. Schneider
Am J Psychiatry Published April 15,
2009
4< -
Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and
Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)
Michael
Davidson, Silvana Galderisi, Mark Weiser, Nomi Werbeloff, Wolfgang W.
Fleischhacker, Richard S. Keefe, Han Boter, Ireneus P.M. Keet, Dan Prelipceanu,
Janusz K. Rybakowski, Jan Libiger, Martina Hummer, Sonia Dollfus, Juan J.
López-Ibor, Luchezar G. Hranov, Wolfgang Gaebel, Joseph Peuskens, Nils
Lindefors, Anita Riechler-Rössler, and René S. Kahn
Am J Psychiatry Published April 15,
2009
3 -
Prenatal Exposure to Maternal Infection and Executive Dysfunction in Adult
Schizophrenia
Alan
S. Brown, Sophia Vinogradov, William S. Kremen, John H. Poole, Raymond F.
Deicken, Justin D. Penner, Ian W. McKeague, Anna Kochetkova, David Kern, and
Catherine A. Schaefer
Am J Psychiatry Published April 15,
2009
GRATIS 3! - Substance Use Disorders in
Schizophrenia—Clinical Implications of Comorbidity
Nora
D. Volkow
Schizophrenia
Bulletin 2009 35(3):469-472
3! -
Prenatal Malnutrition and Adult Schizophrenia: Further Evidence
From the 1959-1961 Chinese Famine
Ming-Qing
Xu, Wen-Sheng Sun, Ben-Xiu Liu, Guo-Yin Feng, Lan Yu, Lawrence
Yang, Guang He, Pak Sham, Ezra Susser, David St. Clair and Lin He
Schizophrenia
Bulletin 2009 35(3):568-576
3! -
Relation of Schizophrenia Prevalence to Latitude, Climate, Fish Consumption,
Infant Mortality, and Skin Color: A Role for Prenatal Vitamin D Deficiency and
Infections?
Dennis
K. Kinney, Pamela Teixeira, Diane Hsu, Siena C. Napoleon, David J. Crowley,
Andrea Miller, William Hyman and Emerald Huang
Schizophrenia
Bulletin 2009 35(3):582-595
3! -
The Antecedents of Schizophrenia: A Review of Birth Cohort Studies
Joy
Welham, Matti Isohanni, Peter Jones and John McGrath
Schizophrenia
Bulletin 2009 35(3):603-623
3! -
Association Between Paternal Schizophrenia and Low Birthweight: A Nationwide
Population-Based Study
Herng-Ching
Lin, Chao-Hsiun Tang and Hsin-Chien Lee
Schizophrenia
Bulletin 2009 35(3):624-630
3! -
Association Between Prenatal Exposure to Bacterial Infection and Risk of
Schizophrenia
Holger
J. Sørensen, Erik L. Mortensen, June M. Reinisch and Sarnoff A. Mednick
Schizophrenia
Bulletin 2009 35(3):631-637
3! -
Life Events and High-Trait Reactivity Together Predict Psychotic Symptom
Increases in Schizophrenia
Nancy
M. Docherty, Annie St-Hilaire, Jennifer M. Aakre and James P. Seghers
Schizophrenia
Bulletin 2009 35(3):638-645
3 - Remission in
schizophrenia: analysis in a naturalistic setting
Jonas Eberhard, Sten Levander and Eva Lindström
Comprehensive Psychiatry. Volume 50, Issue 3,
May-June 2009, Pages 200-208
3! - Impact of
haloperidol and quetiapine on the expression of genes encoding antioxidant
enzymes in human neuroblastoma SH-SY5Y cells
Andreas Johannes Schmidt, Ulrich Michael Hemmeter, Jürgen-Christian
Krieg, Helmut Vedder and Philip Heiser
Journal of Psychiatric Research. Volume 43, Issue 8, May
2009, Pages 818-823
3! -
Role of different monoamine receptors controlling
MK-801-induced release of serotonin and glutamate in the medial prefrontal
cortex: relevance for antipsychotic action
Xavier López-Gil,
Francesc Artigas and Albert Adell
The
International Journal of Neuropsychopharmacology, Volume 12, Issue 04, May
2009, pp 487-499
3! - The efficacies of clozapine and haloperidol
in refractory schizophrenia are related to DTNBP1 variation
Zuo
L, Luo X, Krystal JH, Cramer J, Charney DS, Gelernter J
Pharmacogenet Genomics. 2009 Apr 14. [Epub ahead of
print]
3 - Subjective
wellbeing under quetiapine treatment: Effect of diagnosis, mood state, and
anxiety
Martin Lambert, Dieter Naber, Anne Karow, Christian G. Huber, Jürgen
Köhler, Joachim Heymann and Benno G. Schimmelmann
Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages
72-79
5 - Ziprasidone vs
clozapine in schizophrenia patients refractory to multiple antipsychotic
treatments: The MOZART study
Emilio Sacchetti, Alessandro Galluzzo, Paolo Valsecchi, Fabio Romeo,
Barbara Gorini, Lewis Warrington and on behalf of the INITIATE Study Group
Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages
80-89
3! - Aripiprazole
brain concentration is altered in P-glycoprotein deficient mice
Jun-Sheng Wang, Hao-Jie Zhu, Jennifer L. Donovan, Hong-Jie Yuan, John S.
Markowitz, Mark E. Geesey and C. Lindsay DeVane
Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages
90-94
5< - Weight gain,
metabolic parameters, and the impact of race in aggressive inpatients
randomized to double-blind clozapine, olanzapine or haloperidol
Menahem Krakowski, Pal Czobor and Leslie Citrome
Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages
95-102
4 - Weight effects
associated with antipsychotics: A comprehensive database analysis
Bruce Parsons, David B. Allison, Antony Loebel, Kathryn Williams, Earl
Giller, Steven Romano and Cynthia Siu
Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages
103-110
3 - Cognitive and
antismoking effects of varenicline in patients with schizophrenia or
schizoaffective disorder
Robert C. Smith, Jean-Pierre Lindenmayer, John M. Davis, James Cornwell,
Kathryn Noth, Sanjay Gupta, Henry Sershen and Abel Lajtha
Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages
149-155
3! - Amisulpride doses and plasma levels in different
age groups of patients with schizophrenia or schizoaffective disorder
MJ Müller, FX Eich, B Regenbogen, J Sachse, S
Härtter, C Hiemke
Journal
of Psychopharmacology, Vol. 23, No. 3, 278-286 (2009)
3 - Efficacy and tolerability of ziprasidone versus
risperidone as augmentation in patients partially responsive to clozapine: a
randomised controlled clinical trial
M Zink, A Kuwilsky, B Krumm, H Dressing
Journal
of Psychopharmacology, Vol. 23, No. 3, 305-314 (2009)
3 - WAY-163909, a 5-HT2C agonist, enhances
the preclinical potency of current antipsychotics
Steven M. Grauer,
Radka Graf, Rachel Navarra, Amy Sung, Sheree F. Logue,
Gary Stack, Christine Huselton, Zhi Liu,
Thomas A. Comery, Karen L. Marquis and
Sharon Rosenzweig-Lipson
Psychopharmacology.
Volume 204, Number 1 / May, 2009: 37-48
3! - Superoxide dismutase and cytokines in chronic
patients with schizophrenia: association with psychopathology and response to
antipsychotics
Xiang Yang Zhang,
Dong Feng Zhou, Ling Yan Qi, Song Chen,
Lian Yuan Cao, Da Chun Chen, Mei Hong Xiu,
Fan Wang, Gui Ying Wu, Lin Lu, Therese A. Kosten
and Thomas R. Kosten
Psychopharmacology.
Volume 204, Number 1 / May, 2009: 177-184
3 - Relationship between response to risperidone,
plasma concentrations of risperidone and CYP3A4
polymorphisms in schizophrenia patients
J Du, A Zhang, L Wang, J Xuan, L Yu, R Che, X Li, N
Gu, Z Lin, G Feng, Q Xing, and L He
Journal
of Psychopharmacology On Line First April 2009
3 -
Schizophrenia: From the brain to peripheral markers. A consensus paper of the
WFSBP task force on biological markers
Gerald Stober; Dorit
Ben-Shachar; M. Cardon; Peter Falkai; Alfred N. Fonteh;
Micha Gawlik; Birte Y. Glenthoj; Edna Grunblatt; Assen
Jablensky; Yong-Ku Kim; Johannes Kornhuber; Thomas F.
McNeil; Norbert Muller; Bob Oranje; Toshikazu Saito;
Mohamed Saoud; Andrea Schmitt; Michal Schwartz; Johannes
Thome; Marat Uzbekov; Nuria Durany; Peter Riederer
World
Journal of Biological Psychiatry, Volume10, Issue 2 May 2009, pages 127 - 155
3 -
Effect of donepezil added to atypical antipsychotics on cognition in patients
with schizophrenia: An open-label trial
Young-Chul Chung; Chun-Rong Lee;
Tae-Won Park; Keum-Hwa Yang; Ki-Won Kim
World
Journal of Biological Psychiatry, Volume 10, Issue 2 May 2009, pages 156 - 162
3 -
Untreated illness duration correlates with gray matter loss in first-episode
psychoses
Bangalore, Srihari
S; Goradia, Dhruman D; Nutche, Jeffrey; Diwadkar, Vaibhav A; Prasad, Konasale
M.R; Keshavan, Matcheri S
NeuroReport:
6 May 2009 - Volume 20 - Issue 7 - pp 729-734
3! -
Neurocognitive Effectiveness of Haloperidol, Risperidone, and Olanzapine in
First-Episode Psychosis: A Randomized, Controlled 1-Year Follow-Up Comparison
Benedicto Crespo-Facorro, José M.
Rodríguez-Sánchez, Rocío Pérez-Iglesias, Ignacio Mata, Rosa Ayesa, MariLuz
Ramirez-Bonilla, Obdulia Martínez-Garcia, and José L. Vázquez-Barquero
J Clin
Psychiatry April 21, 2009: e1-e13
3 - Self-reported
sedation profile of immediate-release quetiapine fumarate compared with
extended-release quetiapine fumarate during dose initiation: A randomized,
double-blind, crossover study in healthy adult subjects
Catherine Datto, Lovisa Berggren, Jitendra B. Patel and Hans Eriksson
Clinical Therapeutics. Volume 31, Issue 3, March 2009, Pages 492-502
GRATIS 3 - An Epidemiologic
Study of Psychotropic Medication and Obesity-Related Chronic Illnesses in Older
Psychiatric Patients
Stephen Kisely, Martha Cox, Leslie Anne Campbell,
Charmaine Cooke, David Gardner
Can J Psychiatry. 2009;54(4):269–274
GRATIS 3 - Improvement of
Metabolic Risk Profile Under Second-Generation
Antipsychotics: A Pilot Intervention Study
Mélissa Blouin, Mario Binet, Roch-Hugo Bouchard,
Marc-André Roy, Jean-Pierre Després, Natalie Alméras
Can J Psychiatry. 2009;54(4):275–279
GRATIS 3 - Comorbid Cannabis Misuse in
Psychotic Disorders: Treatment Strategies
Wilfrid Noël Raby
Primary Psychiatry. 2009;16(4):29-34
GRATIS 3! -
Review of the efficacy of placebo in comparative clinical
trials between typical and atypical antipsychotics
OLIVEIRA,
Irismar Reis de; NUNES, Paulo
Menezes; COUTINHO, Domingos Macedo and SENA, Eduardo
Pondé de
Rev. Bras. Psiquiatr. 2009, vol.31, n.1, pp. 52-56
3! – Atypical Antipsychotic Drugs and Diabetes
Mellitus in the US Food and Drug Administration Adverse Event Database: A
Systematic Bayesian Signal Detection Analysis
Baker RA et al.
Psychopharmacol Bull 2009; 42:11-31
| Regresar a RESÚMENES ABRIL 2009 |